[ad_1]
READ MORE ARTICLES ON
Recordati announced the agreement between Fimei and Cvc Capital Partners for the sale of the majority stake of the Italian pharmaceutical group Friday after the closing of the markets.
Recordati announced Friday after the closing of the deal between Fimei and Cvc Capital Partners for the sale of the majority stake of the Italian pharmaceutical group. Luxembourg private customers will pay about 3 billion euros (about 2.3 billion euros in cash, plus 750 million euros of subordinated long – term financial instruments) for 51.8 million euros. % of the capital held by the holding of the Recordati family. Following the closing of the transaction, first scheduled for Bloomberg in early June, Cvc will launch an offer on minority interests at an indicative price of € 28 per share. Recordati closed at 1.55% on Friday in Milan, worth 34.06 euros, against the 0.90% rise of the Ftse Mib.
(RR – www.ftaonline.com)
Source link
